Nature Biotechnology 2000 Liz Fletcher - Abstracts
| Nature Biotechnology 2000 Liz Fletcher | |||||
| Title | Subject | Authors | |||
|---|---|---|---|---|---|
| Cantab failure shows need for wide portfolio.(Analysis) | Business | Liz Fletcher | |||
| Guilford acquires Gliatech in strategic deal. | Business | Liz Fletcher | |||
| Millennium and Aventis in unique pact.(Aventis Pharma) | Business | Liz Fletcher | |||
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.